Mount Sinai Developing an End-to-End Diagnostics Solution for Covid-19
Mount Sinai researchers are working to design and validate a clinical pathology laboratory solution for testing, treatment, and monitoring of covid-19.
Read MorePosted by | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Mount Sinai researchers are working to design and validate a clinical pathology laboratory solution for testing, treatment, and monitoring of covid-19.
Read MorePosted by | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Wider deployment of the covid-19 test, already in use in the Hackensack Meridian Health network, will meet a crucial need amid the continuing spread of the novel coronavirus.
Read MorePosted by | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The laboratory is increasing its covid-19 testing capacity of 1,000 tests per day, with plans to reach 28,000 per week in the coming weeks.
Read MorePosted by | Mar 31, 2020 | Cleaners & Disinfectants, Covid 19, Emerging & Zoonotic Diseases, Eyeware & Facial Protection, Eyewash & Showers, Infectious Diseases, Lab Safety, Labcoats, Gloves & Apparel, Power Surge Protectors |
FDA has acted to facilitate the importation of products—including personal protective equipment and medical devices needed to help fight the covid-19 pandemic—into the United States.
Read MorePosted by | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The trial will evaluate the safety and efficacy of intravenous tocilizumab on top of standard of care in hospitalized adult patients with severe covid-19 pneumonia.
Read More